SCHEMBL4926673

SCHEMBL4926673

CCOC(=O)c1[nH]c2ccc(NS(=O)(=O)c3ccc(C(C)(C)C)cc3)cc2c1-c1ccc(Cl)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.55
HPGD P15428 2/20 0.55
CYP1A2 P05177 2/20 0.55
CYP2C19 P33261 2/20 0.55
XBP1 P17861 1/20 0.55
HIF1A Q16665 4/20 0.54
BRD4 O60885 2/20 0.48
PPARG P37231 1/20 0.46
SERPINE1 P05121 1/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
CSF1R P07333 1/20 0.44
ALOX15 P16050 1/20 0.44
MAPK1 P28482 1/20 0.44
HSD17B10 Q99714 1/20 0.44
GPR119 Q8TDV5 3/20 0.43
LMNA P02545 1/20 0.42
TP53 P04637 1/20 0.42
MAPT P10636 1/20 0.42
ACR P10323 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4922707 0.93 HIF1A (0.56) ALDH1A1HPGDCYP1A2CYP2C19XBP1
SCHEMBL4586922 0.91 ALDH1A1 (0.56) ALDH1A1HPGDCYP1A2CYP2C19XBP1
SCHEMBL4931705 0.91 ALDH1A1 (0.55) ALDH1A1HPGDCYP1A2CYP2C19XBP1
SCHEMBL4927908 0.91 HIF1A (0.54) ALDH1A1HPGDCYP1A2CYP2C19XBP1
SCHEMBL4923602 0.90 HIF1A (0.53) ALDH1A1HPGDCYP1A2CYP2C19XBP1
Dimethylamine SCHEMBL4923606 0.90 ALDH1A1 (0.55) ALDH1A1HPGDCYP1A2CYP2C19XBP1
SCHEMBL4932283 0.90 HIF1A (0.54) ALDH1A1HPGDCYP1A2CYP2C19XBP1
SCHEMBL4929390 0.89 HIF1A (0.52) ALDH1A1HPGDCYP1A2CYP2C19XBP1
SCHEMBL3946651 0.87 BRD4 (0.53) ALDH1A1BRD4SERPINE1MEN1KMT2A
SCHEMBL4929352 0.87 HIF1A (0.54) ALDH1A1HPGDCYP1A2CYP2C19XBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080004268-A1 INHIBITORS OF SOLUBLE ADENYLATE CYCLASE NGUYEN DUY 2008-01-03 US disclosed
US-20060074084-A1 Inhibitors of soluble adenylate cyclase BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2006-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004268-A1 INHIBITORS OF SOLUBLE ADENYLATE CYCLASE ADCY1, ADCY2, ADCY5 ALDH1A1 268/4885HPGD 135/4885CYP1A2 1151/4885
US-20060074084-A1 Inhibitors of soluble adenylate cyclase ADCY1, ADCY2, ADCY5 ALDH1A1 268/4885HPGD 135/4885CYP1A2 1151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.